BREAST CANCER BASE

Breast cancer patients with radiotherapy and chemotherapy to do what courses Generally, a site with only one course, radical radiotherapy achieved in a meeting, usually no longer OK 2nd radiotherapy. First, because of...

Chemotherapy for Breast Cancer What role Chemotherapy is the role of cytotoxic drug eradication Yat into the bloodstream and lymphatic system cancer, when the transfer occurred and...

A 10-year study showed that the node-positive breast cancer before menopause women to accept if epirubicin-based six cycles of chemotherapy, the efficacy is better than three cycles. Cancer spread to the lymph nodes of women, extended treatment time was significantly better disease-free survival. The advantages of combined chemotherapy known for many years, this was the first one on different cancer therapy duration of the test were compared, the researchers said, "this trial clearly showed long-term use of epirubicin, fluorouracil and cyclophosphamide (FEC) treatment, the efficacy was significantly better than short-term therapy. "

The trial published in the January 2003 publication of the "Journal of Clinical Oncology", which 602 cases with lymph node-positive breast cancer in premenopausal women FEC treatment dose intensity and duration of the assessment. These patients were done breast cancer mastectomy or resection of tumor and lymph nodes under the arm removed. After surgery, patients were randomly divided into three groups : epirubicin 50mg/m2 six cycles of FEC, epirubicin 50mg/m2 the FEC three cycles, epirubicin 75mg/m2 three cycles of FEC. With anti-decade results show that low-dose epirubicin 50mg/m2 six cycles without cancer survival rate was significantly higher than three cycles, respectively 53.4% and 42.5%, the dose of 75mg/m2 The survival rate of 43.6%. Three decades group overall survival were : 50mg/m2 FEC six cycles 64.3%, 56.6% 3 cycles, the cycle 75mg/m2 59.7% 3. Researchers said, "long-term follow-dose regardless of the result, the FEC 50mg/m2 six cycles of efficacy in cancer-free survival rates significantly higher than three cycles." As for survival, receive six cycles FEC 50mg/m2 significantly superior efficacy of the three cycles.

Researchers said that the almost three group therapy there were very few serious side effects, and no deaths related to the toxicity of only five people with heart disease, three patients had primitive acute myelogenous leukemia (AML), which is the vice adjuvant chemotherapy response.

Breast cancer surgery time may affect the choice of survival More evidence that pre-menopausal women suffering from breast cancer surgery time the choice will affect survival. London hospitals Guy S....

Why breast cancer need chemotherapy, which often use chemotherapy drugs Chemotherapy is a cancer drug for the treatment of malignant tumors. These drugs in cell growth and reproduction of various segments of the ...

Application of breast cancer after Femara for endocrine therapy? No chemotherapy directly with Femara work? The world at present, after receptor-positive breast cancer patients using complementary therapy...

Yes lobular hyperplasia early breast cancer lesions? Breast lobular hyperplasia neither inflammatory nor tumors, breast tissue is physiological subinvolution hyperplasia and the normal tissue d...

Uncovered and carrots can prevent breast cancer Xinhua News Agency, Mexico City, May 9 (Reporter Song Xinde) - Mexico, the National Polytechnic medical researchers, after years of study a...

Breast cancer chemotherapy administration results Recently in Beijing at the 2003 new breast cancer treatment at the seminar, from the United States BaylorSammons breast cancer experts in t...

What is systemic chemotherapy and local chemotherapy

Mastalgias thing is how